SCHEMBL29618375

SCHEMBL29618375

Ic1ccc2c(c1)CCC2

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PNMT P11086 6/20 0.54
ADRA2A P08913 2/20 0.54
ADRA2B P18089 2/20 0.54
ADRA2C P18825 2/20 0.54
ALDH1A1 P00352 1/20 0.45
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA14 Q9ULX7 1/20 0.43
TDP2 O95551 2/20 0.39
TSHR P16473 1/20 0.39
RAPGEF4 Q8WZA2 1/20 0.37
STS P08842 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4525476 1.00 PNMT (0.54) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL1706815 0.95 PNMT (0.54) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL13193777 0.92 PNMT (0.52) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL18454733 0.89
SCHEMBL31122821 0.89 PNMT (0.58) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL20978055 0.78 ADRA2A (0.57) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL8041840 0.78 PNMT (0.77) PNMTADRA2AADRA2BADRA2C
SCHEMBL15424369 0.78 PNMT (0.48) PNMTADRA2AADRA2BADRA2CALDH1A1
SCHEMBL8055291 0.77 DRD1 (0.50) PNMTADRA2AADRA2BADRA2C
SCHEMBL2988432 0.77 PNMT (0.67) PNMTADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022121805-A1 FUSED RING COMPOUND AS NAV1.8 INHIBITOR AND USE THEREOF 成都康弘药业集团股份有限公司 2022-06-16 WO disclosed
CN-114591293-A Fused ring compound as Nav1.8 inhibitor and application thereof 成都康弘药业集团股份有限公司 2022-06-07 CN disclosed